As of June 8, 2025, Varex Imaging Corp (VREX) reports a EV/EBITDA of 9.82.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Varex Imaging Corp's EV/EBITDA to Peers
To better understand Varex Imaging Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Varex Imaging Corp (VREX) | 9.82 |
| AxoGen Inc (AXGN) | 69.56 |
| Intricon Corp (IIN) | 47.61 |
| LeMaitre Vascular Inc (LMAT) | 32.51 |
| Artivion Inc (CRY) | 22.59 |
| Natus Medical Inc (NTUS) | 21.04 |
Compared to its competitors, Varex Imaging Corp's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.